Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells

Anticancer Research

Volumn 30, Issue 3, 2010, Pages 945-952

  Chen, Ya Yin ^a   Chiang, Su Yin ^a   Lin, Jaung Geng ^a   Yang, Jai Sing ^b   Yi Shih, Ma ^a   Liao, Ching Lung ^a   Lai, Tung Yuan ^a,b   Tang, Nou Ying ^a   Chung, Jing Gung ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ATM; BRCA1; Comet assay; RT PCR

Indexed keywords

ALOE EMODIN; ATM PROTEIN; ATR PROTEIN; BRCA1 PROTEIN; DNA DEPENDENT PROTEIN KINASE; EMODIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; RHEIN; STRATIFIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; DNA SEQUENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TONGUE CANCER;

ANTHRAQUINONES; BRCA1 PROTEIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; COMET ASSAY; DNA DAMAGE; DNA MODIFICATION METHYLASES; DNA REPAIR; DNA REPAIR ENZYMES; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; EMODIN; ENZYME INHIBITORS; EXONUCLEASES; GENE EXPRESSION; HUMANS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 77951040905     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Morgan SE and Kastan MB: p53 and ATM: cell cycle, cell death, and cancer. Adv Cancer Res 71: 1-25, 1997.
2. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
3. Cox LS and Lane DP: Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 17: 501-508, 1995.
4. 2/M progression. Mol Cell 1: 3-11, 1997.
5. Waldman T, Lengauer C, Kinzler KW and Vogelstein B: Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713-716, 1996.
6. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ: Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557, 1995.
7. Gensler HL and Bernstein H: DNA damage as the primary cause of aging. Q Rev Biol 56: 279-303, 1981.
8. Wang Z, Wu X and Friedberg EC: The detection and measurement of base and nucleotide excision repair in cell-free extracts of the yeast Saccharomyces cerevisiae. Methods 7: 177-186 1995.
9. Tsai TH and Chen CF: Ultraviolet spectrum identification of emodin in rabbit plasma by HPLC and its pharmacokinetics application. Asia Pac J Pharmacol 7: 53-56, 1992.
10. Liang JW, Hsiu SL, Huang HC and Lee-Chao PD: HPLC analysis of emodin in serum, herbs and Chinese herbal prescriptions. J Food Drug Anal 1: 251-257, 1993.
11. Huang HC, Chu SH and Chao PD: Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur J Pharmacol 198: 211-213, 1991.
12. +-ATPase of the rabbit renal medulla and their diuretic action. Acta Pharmaceutica Sinica 23: 17-20, 1988.
13. Koyama M, Kelly TR and Watanabe KA: Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure activity relationship studies. J Med Chem 31: 283-284, 1988.
14. Su HY, Cherng SH, Chen CC and Lee H: Emodin inhibits the mutagenicity and DNA adducts induced by 1-nitropyrene. Mutat Res 329: 205-212, 1995.
15. Yu CX, Zhang XQ, Kang LD, Zhang PJ, Chen WW, Liu WW, Liu QW and Zhang JY: Emodin induces apoptosis in human prostate cancer cell LNCaP. Asian J Androl 10: 625-634, 2008.
16. Su YT, Chang HL, Shyue SK and Hsu SL: Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol 70: 229-241, 2005.
17. Wang XD, Gu LQ and Wu JY: Apoptosis-inducing activity of new pyrazole emodin derivatives in human hepatocellular carcinoma HepG2 cells. Biol Pharm Bull 30: 1113-1116, 2007.
18. Huang Z, Chen G and Shi P: Emodin-induced apoptosis in human breast cancer BCap-37 cells through the mitochondrial signaling pathway. Arch Pharm Res 31: 742-748, 2008.
19. Lin SY, Lai WW, Ho CC, Yu FS, Chen GW, Yang JS, Liu KC, Lin ML, Wu PP, Fan MJ and Chung JG: Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res 29: 327-335, 2009.
20. Yang F, Zhang T, Tian G, Cao H, Liu Q and Ito Y: Preparative isolation and purification of hydroxyanthraquinones from Rheum officinale Baill by high-speed counter-current chromatography using pH-modulated stepwise elution. J Chromatogr A 858: 103-107, 1999.
21. Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M and Palu G: Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 60: 2800-2804, 2000.
22. Heidemann A, Volkner W and Mengs U: Genotoxicity of aloeemodin in vitro and in vivo. Mutat Res 367: 123-133, 1996.
23. Wolfle D, Schmutte C, Westendorf J and Marquardt H: Hydroxyanthraquinones as tumor promoters: enhancement of malignant transformation of C3H mouse fibroblasts and growth stimulation of primary rat hepatocytes. Cancer Res 50: 6540-6544, 1990.
24. Pecere T, Sarinella F, Salata C, Gatto B, Bet A, Dalla Vecchia F, Diaspro A, Carli M, Palumbo M and Palu G: Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin. Int J Cancer 106: 836-847, 2003.
25. Kuo PL, Lin TC and Lin CC: The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci 71: 1879-1892, 2002.
26. Lee HZ: Protein kinase C involvement in aloe-emodin- and emodin-induced apoptosis in lung carcinoma cell. Br J Pharmacol 134: 1093-1103, 2001.
27. Chen SH, Lin KY, Chang CC, Fang CL and Lin CP: Aloe-emodin-induced apoptosis in human gastric carcinoma cells. Food Chem Toxicol 45: 2296-2303, 2007.
28. Lai MY, Hour MJ, Wing-Cheung Leung H, Yang WH and Lee HZ: Chaperones are the target in aloe-emodin-induced human lung nonsmall carcinoma H460 cell apoptosis. Eur J Pharmacol 573: 1-10, 2007.
29. Lu GD, Shen HM, Chung MC and Ong CN: Critical role of oxidative stress and sustained JNK activation in aloe-emodin-mediated apoptotic cell death in human hepatoma cells. Carcinogenesis 28: 1937-1945, 2007.
30. Chiu TH, Lai WW, Hsia TC, Yang JS, Lai TY, Wu PP, Ma CY, Yeh CC, Ho CC, Lu HF, Wood WG and Chung JG: Aloe-emodin induces cell death through S-phase arrest and caspase-dependent pathways in human tongue squamous cancer SCC-4 cells. Anticancer Res 29: 4503-4511, 2009.
31. Lin S, Li JJ, Fujii M and Hou DX: Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway. Int J Oncol 22: 829-833, 2003.
32. Miccadei S, Pulselli R and Floridi A: Effect of lonidamine and rhein on the phosphorylation potential generated by respiring rat liver mitochondria. Anticancer Res 13: 1507-1510, 1993.
33. Delpino A, Paggi MG, Gentile PF, Castiglione S, Bruno T, Benass M and Floridi A: Protein synthetic activity and adenylate energy charge in Rhein-treated cultured human glioma cells. Cancer Biochem Biophys 12: 241-252, 1992.
34. Castiglione S, Fanciulli M, Bruno T, Evangelista M, Del Carlo C, Paggi MG, Chersi A and Floridi A: Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions. Anticancer Drugs 4: 407-414, 1993.
35. Raimondi F, Santoro P, Maiuri L, Londei M, Annunziata S, Ciccimarra F and Rubino A: Reactive nitrogen species modulate the effects of rhein, an active component of senna laxatives, on human epithelium in vitro. J Pediatr Gastroenterol Nutr 34: 529-534, 2002.
36. Lin S, Fujii M and Hou DX: Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway. Arch Biochem Biophys 418: 99-107, 2003.
37. 2+ on rhein-induced apoptosis in human cervical cancer Ca Ski cells. Anticancer Res 27: 379-389, 2007.
38. 2+-dependent mitochondrial death pathway in human nasopharyngeal carcinoma cells. Anticancer Res 27: 3313-3322, 2007.
39. Lai WW, Yang JS, Lai KC, Kuo CL, Hsu CK, Wang CK, Chang CY, Lin JJ, Tang NY, Chen PY, Huang WW and Chung JG: Rhein induced apoptosis through endoplasmic reticulum stress, caspase- and mitochondria-dependent pathways in SCC-4 human tongue squamous cancer cells. In Vivo 23: 309-316, 2009.
40. 2+ on rhein-induced apoptosis in A-549 human lung cancer cells. Anticancer Res 29: 309-318, 2009.
41. Lu HF, Yang JS, Lai KC, Hsu SC, Hsueh SC, Chen YL, Chiang JH, Lu CC, Lo C, Yang MD and Chung JG: Curcumin-induced DNA damage and inhibited DNA repair genes expressions in mouse-rat hybrid retina ganglion cells (N18). Neurochem Res 34: 1491-1497, 2009.
42. Olive PL, Banath JP and Durand RE: Detection of etoposide resistance by measuring DNA damage in individual Chinese hamster cells. J Natl Cancer Inst 82: 779-783, 1990.
43. Ashby J, Tinwell H, Lefevre PA and Browne MA: The single cell gel electrophoresis assay for induced DNA damage (comet assay): measurement of tail length and moment. Mutagenesis 10: 85-90, 1995.
44. Pool-Zobel BL, Lotzmann N, Knoll M, Kuchenmeister F, Lambertz R, Leucht U, Schroder HG and Schmezer P: Detection of genotoxic effects in human gastric and nasal mucosa cells isolated from biopsy samples. Environ Mol Mutagen 24: 23-45, 1994.
45. Tice RR, Andrews PW and Singh NP: The single cell gel assay: a sensitive technique for evaluating intercellular differences in DNA damage and repair. Basic Life Sci 53: 291-301, 1990.
46. Terleth C, van de Putte P and Brouwer J: New insights in DNA repair: preferential repair of transcriptionally active DNA. Mutagenesis 6: 103-111, 1991.
47. Hanawalt PC: Heterogeneity of DNA repair at the gene level. Mutat Res 247: 203-211, 1991.
48. Hanawalt PC: DNA repair comes of age. Mutat Res 336: 101-113, 1995.
49. Shiotani B and Zou L: Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. Mol Cel 33: 547-558, 2009.
50. Choi JH, Sancar A and Lindsey-Boltz LA: The human ATR-mediated DNA damage checkpoint in a reconstituted system. Methods 48: 3-7, 2009.
51. Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171-182, 2002.
52. Neal CL, Yao J, Yang W, Zhou X, Nguyen NT, Lu J, Danes CG, Guo H, Lan KH, Ensor J, Hittelman W, Hung MC and Yu D: 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res 69: 3425-3432, 2009.
53. Mi J, Dziegielewski J, Bolesta E, Brautigan DL and Larner JM: Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6. PLoS One 4: e4395, 2009.
54. Jesien-Lewandowicz E, Jesionek-Kupnicka D, Zawlik I, Szybka M, Kulczycka-Wojdala D, Rieske P, Sieruta M, Jaskolski D, Och W, Skowronski W, Sikorska B, Potemski P, Papierz W, Liberski PP and Kordek R: High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations. Cancer Genet Cytogenet 188: 77-82, 2009.